Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation

Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation

Background: Cancer patients are highly prone to infectious diseases. While undergoing antineoplastic treatment, the risk of severe symptoms upon infection increases, necessitating efficient protective measures, such as vaccination. For patients receiving radiotherapy, there is no specific informatio...

Full description

Bibliographic Details
Main Authors: Paul Thöne, Margot Egger, Marija Geroldinger-Simic, Harald Kindermann, Lukas Kocik, Nicola Karasek, Barbara Fischerlehner, Kurt Spiegl, Georg Gruber, Bernhard Aschacher, Benjamin Dieplinger, Martin Clodi, Hans Geinitz
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Vaccines
Subjects:
seroconversion
humoral immune response
kinetic
antibody persistence
side effects
COVID-19
Online Access:https://www.mdpi.com/2076-393X/12/3/275

Internet

https://www.mdpi.com/2076-393X/12/3/275

Similar Items